Valued at a market cap of $40.4 billion, Corteva, Inc. (CTVA) operates in the agriculture business and develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. The Indianapolis, Indiana-based company also supplies products that protect crops against weeds, insects, and other pests, and also enhance crop health.
Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Corteva fits the label perfectly, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the agricultural inputs industry. The company’s key strengths lie in its cutting-edge research and development, which drive innovation in genetically modified (GM) and non-GM seeds, as well as advanced crop protection products. The company benefits from a strong market presence, with a broad portfolio of high-yielding seeds and sustainable agricultural solutions tailored to diverse climates and geographies.
